D. E. Shaw & Co., Inc. Eli Lilly & CO Put Options Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

Put Options

22 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$772.14 - $960.02 $26.4 Million - $32.8 Million	34,200 Added 11.93%	320,800 $284 Million
Q2 2024 Aug 14, 2024	SELL	$724.87 - $909.04 $28.7 Million - $36 Million	-39,600 Reduced 12.14%	286,600 $259 Million
Q1 2024 May 15, 2024	BUY	$592.2 - $792.28 $32.5 Million - $43.4 Million	54,800 Added 20.19%	326,200 $254 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $53.3 Million - $62.8 Million	101,400 Added 59.65%	271,400 $158 Million
Q3 2023 Nov 14, 2023	BUY	$434.7 - $599.3 $21 Million - $28.9 Million	48,300 Added 39.69%	170,000 $91.3 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $2.91 Million - $3.89 Million	-8,300 Reduced 6.38%	121,700 $57.1 Million
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $2.86 Million - $3.36 Million	9,200 Added 7.62%	130,000 $44.6 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $3.47 Million - $4.05 Million	10,800 Added 9.82%	120,800 $44.2 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $32.6 Million - $37.2 Million	110,000 New	110,000 $35.6 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $13.5 Million - $16.7 Million	60,000 Added 1500.0%	64,000 $17.7 Million
Q2 2021 Aug 16, 2021	SELL	$180.55 - $233.54 $3 Million - $3.88 Million	-16,600 Reduced 80.58%	4,000 $918,000
Q3 2020 Nov 16, 2020	SELL	$146.22 - $169.13 $2.27 Million - $2.62 Million	-15,500 Reduced 42.94%	20,600 $3.05 Million
Q1 2020 May 15, 2020	BUY	$119.05 - $147.35 $3.11 Million - $3.85 Million	26,100 Added 261.0%	36,100 $5.01 Million
Q4 2019 Feb 14, 2020	SELL	$106.92 - $132.43 $5.35 Million - $6.62 Million	-50,000 Reduced 83.33%	10,000 $1.31 Million
Q3 2019 Nov 14, 2019	BUY	$106.79 - $116.16 $5.34 Million - $5.81 Million	50,000 Added 500.0%	60,000 $6.71 Million
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $53.3 Million - $62.3 Million	-481,500 Reduced 97.97%	10,000 $1.11 Million
Q1 2019 May 15, 2019	BUY	$111.31 - $131.02 $40.5 Million - $47.6 Million	363,400 Added 283.68%	491,500 $63.8 Million
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $7.21 Million - $8.08 Million	68,100 Added 113.5%	128,100 $14.8 Million
Q3 2018 Nov 14, 2018	SELL	$85.86 - $107.31 $7.85 Million - $9.81 Million	-91,400 Reduced 60.37%	60,000 $6.44 Million
Q2 2018 Aug 14, 2018	SELL	$75.7 - $86.88 $492,050 - $564,720	-6,500 Reduced 4.12%	151,400 $12.9 Million
Q1 2018 May 15, 2018	BUY	$74.21 - $87.6 $8.38 Million - $9.89 Million	112,900 Added 250.89%	157,900 $12.2 Million
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $3.47 Million - $3.85 Million	45,000	45,000 $3.85 Million

Others Institutions Holding LLY

# of Institutions

4,007

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

Lilly Endowment Inc Indianapolis, IN

96.9M
Shares

$77.5 Billion
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

73.8M
Shares

$59 Billion
1.2% of portfolio
Black Rock Inc. New York, NY

65.9M
Shares

$52.7 Billion
1.37% of portfolio
Pnc Financial Services Group, Inc. Pittsburgh, PA

51.4M
Shares

$41.1 Billion
29.2% of portfolio
State Street Corp Boston, MA

33.9M
Shares

$27.1 Billion
1.24% of portfolio

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $760B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account